Reduced susceptibility to cefixime but not ceftriaxone: an uncertain perspective for the treatment of gonorrhoea in Brazil

Int J Antimicrob Agents. 2017 Apr;49(4):515-516. doi: 10.1016/j.ijantimicag.2017.02.003. Epub 2017 Feb 21.

¹ Institute of Microbiology, Federal University of Rio de Janeiro, Avenida Carlos Chagas Filho 373, CCS, Bloco I, Laboratório I2-59, Cidade Universitária, Rio de Janeiro, RJ 21941-902, Brazil.
² National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329-4027, USA.
³ National Institute of Healthy Quality Control, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, RJ CEP 21040-900, Brazil.
⁴ Institute of Microbiology, Federal University of Rio de Janeiro, Avenida Carlos Chagas Filho 373, CCS, Bloco I, Laboratório I2-59, Cidade Universitária, Rio de Janeiro, RJ 21941-902, Brazil. Electronic address: raquel.bonelli@micro.ufrj.br.

No abstract available

MeSH terms